Stryker (SYK) Stock Forecast & Price Target

16 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

SYK Analyst Ratings

Strong Buy

18 Buy

2 Hold

0 Sell

Based on 20 analysts giving stock ratings to

Stryker

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

SYK Stock 12 Month Forecast

Average Price Target

€324.51

▲(14.99% Upside)

Based on 20 Wall Street analysts offering 12 month price targets for Stryker in the last 3 months. The average price target is €324.51 with a high forecast of €370.52 and a low forecast of €262.90. The average price target represents a 14.99% change from the last price of €282.20.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"257":"€257","314":"€314","371":"€371","285.5":"€285.5","342.5":"€342.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":370.523937,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€370.52</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":324.51025008684206,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€324.51</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":262.8955553,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€262.90</span>\n  </div></div>","useHTML":true}}],"tickPositions":[257,285.5,314,342.5,371],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2025","6":"Mar<br/>2026","9":"Jun<br/>2026","12":"Sep<br/>2026","25":"Sep<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,277.12,284.30491823076926,291.48983646153846,298.6747546923077,305.8596729230769,313.04459115384617,320.22950938461537,327.4144276153846,334.5993458461538,341.7842640769231,348.9691823076923,356.15410053846153,363.33901876923073,{"y":370.523937,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,277.12,280.765403852834,284.410807705668,288.056211558502,291.70161541133604,295.34701926417006,298.992423117004,302.63782696983804,306.28323082267207,309.92863467550603,313.57403852834005,317.2194423811741,320.86484623400804,{"y":324.51025008684206,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,277.12,276.02581194615385,274.9316238923077,273.83743583846154,272.7432477846154,271.64905973076924,270.5548716769231,269.46068362307693,268.3664955692308,267.2723075153846,266.1781194615385,265.0839314076923,263.98974335384617,{"y":262.8955553,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":328.515,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":300.384,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":306.813,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":317.298,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":295.979,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":308.969,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":328.899,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":283.151,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":268.934,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":258.892,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":275.724,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":280.31,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":277.12,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€370.52

Average Price Target€324.51

Lowest Price Target€262.90

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Rick Wise

Stifel Nicolaus

€317.59→€291.13

Buy

3.16%

Upside

Reiterated

09/30/26

Analysts Offer Insights on Healthcare Companies: DocGo (NASDAQ: DCGO), Nektar Therapeutics (NASDAQ: NKTR) and Stryker (NYSE: SYK)

Matthew Taylor

Jefferies

€357.29

Buy

26.61%

Upside

Reiterated

09/22/26

Stryker (SYK) Receives a Buy from Jefferies

Mathew Blackman

TD Cowen

€313.18→€262.9

Hold

-6.84%

Downside

Assigned

09/22/26

Wall Street Analysts Are Neutral on Top Healthcare Picks

Caitlin Roberts

Canaccord Genuity

€352.88→€339.65

Buy

20.36%

Upside

Reiterated

09/18/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Stryker (NYSE: SYK) and Envista Holdings (NYSE: NVST)

Larry Biegelsen

Wells Fargo

€307.01

Buy

8.79%

Upside

Assigned

09/16/26

Analysts Are Bullish on Top Healthcare Stocks: Stryker (SYK), Disc Medicine (IRON)

Shagun Singh Chadha

RBC Capital

€370.52

Buy

31.30%

Upside

Reiterated

09/16/26

Analysts Offer Insights on Healthcare Companies: Amgen (NASDAQ: AMGN), Atricure (NASDAQ: ATRC) and Stryker (NYSE: SYK)

Travis Steed

Bank of America Securities

€335.24

Buy

18.79%

Upside

Reiterated

09/15/26

Analysts' Top Healthcare Picks: Alnylam Pharma (ALNY), Scholar Rock Holding (SRRK)

Joanne Wuensch

Citi

€352→€317.59

Buy

12.54%

Upside

Reiterated

09/10/26

Stryker price target lowered to $360 from $399 at CitiStryker price target lowered to $360 from $399 at Citi

Steven Lichtman

William Blair

―

Buy

―

Reiterated

09/09/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Vik Chopra

BMO Capital

€325.53→€279.66

Buy

-0.90%

Downside

Reiterated

09/09/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Bristol-Myers Squibb (NYSE: BMY), Stryker (NYSE: SYK) and InnovAge Holding (NASDAQ: INNV)

Ryan Zimmerman

BTIG

€315.83

Buy

11.92%

Upside

Reiterated

08/27/26

Analysts Offer Insights on Healthcare Companies: Connect Biopharma Holdings (NASDAQ: CNTB) and Stryker (NYSE: SYK)

Robbie Marcus

J.P. Morgan

€308.77

Buy

9.42%

Upside

Reiterated

08/04/26

Stryker (SYK) Receives a Buy from J.P. Morgan

David Turkaly

Citizens JMP

€388.17→€352.88

Buy

25.05%

Upside

Reiterated

08/03/26

Stryker price target lowered to $400 from $440 at CitizensStryker price target lowered to $400 from $440 at Citizens

Jayson Bedford

Raymond James

€337.88→€326.41

Buy

15.67%

Upside

Reiterated

07/31/26

Stryker price target lowered to $370 from $383 at Raymond JamesStryker price target lowered to $370 from $383 at Raymond James

Richard Newitter

Truist Financial

€291.13→€299.95

Hold

6.29%

Upside

Reiterated

07/31/26

Truist Financial Sticks to Its Hold Rating for Stryker (SYK)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Rick Wise

Stifel Nicolaus

€317.59→€291.13

Buy

3.16%

Upside

Reiterated

09/30/26

Analysts Offer Insights on Healthcare Companies: DocGo (NASDAQ: DCGO), Nektar Therapeutics (NASDAQ: NKTR) and Stryker (NYSE: SYK)

Matthew Taylor

Jefferies

€357.29

Buy

26.61%

Upside

Reiterated

09/22/26

Stryker (SYK) Receives a Buy from Jefferies

Mathew Blackman

TD Cowen

€313.18→€262.9

Hold

-6.84%

Downside

Assigned

09/22/26

Wall Street Analysts Are Neutral on Top Healthcare Picks

Caitlin Roberts

Canaccord Genuity

€352.88→€339.65

Buy

20.36%

Upside

Reiterated

09/18/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Stryker (NYSE: SYK) and Envista Holdings (NYSE: NVST)

Larry Biegelsen

Wells Fargo

€307.01

Buy

8.79%

Upside

Assigned

09/16/26

Analysts Are Bullish on Top Healthcare Stocks: Stryker (SYK), Disc Medicine (IRON)

Shagun Singh Chadha

RBC Capital

€370.52

Buy

31.30%

Upside

Reiterated

09/16/26

Analysts Offer Insights on Healthcare Companies: Amgen (NASDAQ: AMGN), Atricure (NASDAQ: ATRC) and Stryker (NYSE: SYK)

Travis Steed

Bank of America Securities

€335.24

Buy

18.79%

Upside

Reiterated

09/15/26

Analysts' Top Healthcare Picks: Alnylam Pharma (ALNY), Scholar Rock Holding (SRRK)

Joanne Wuensch

Citi

€352→€317.59

Buy

12.54%

Upside

Reiterated

09/10/26

Stryker price target lowered to $360 from $399 at CitiStryker price target lowered to $360 from $399 at Citi

Steven Lichtman

William Blair

―

Buy

―

Reiterated

09/09/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Vik Chopra

BMO Capital

€325.53→€279.66

Buy

-0.90%

Downside

Reiterated

09/09/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Bristol-Myers Squibb (NYSE: BMY), Stryker (NYSE: SYK) and InnovAge Holding (NASDAQ: INNV)

Ryan Zimmerman

BTIG

€315.83

Buy

11.92%

Upside

Reiterated

08/27/26

Analysts Offer Insights on Healthcare Companies: Connect Biopharma Holdings (NASDAQ: CNTB) and Stryker (NYSE: SYK)

Robbie Marcus

J.P. Morgan

€308.77

Buy

9.42%

Upside

Reiterated

08/04/26

Stryker (SYK) Receives a Buy from J.P. Morgan

David Turkaly

Citizens JMP

€388.17→€352.88

Buy

25.05%

Upside

Reiterated

08/03/26

Stryker price target lowered to $400 from $440 at CitizensStryker price target lowered to $400 from $440 at Citizens

Jayson Bedford

Raymond James

€337.88→€326.41

Buy

15.67%

Upside

Reiterated

07/31/26

Stryker price target lowered to $370 from $383 at Raymond JamesStryker price target lowered to $370 from $383 at Raymond James

Richard Newitter

Truist Financial

€291.13→€299.95

Hold

6.29%

Upside

Reiterated

07/31/26

Truist Financial Sticks to Its Hold Rating for Stryker (SYK)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

OMCLOmnicell

KNSAKiniksa Pharmaceuticals

ACHVAchieve Life Sciences

AHCOAdaptHealth

ZVRAZevra Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Stryker

3 Months

Robbie MarcusJ.P. Morgan

Success Rate

14/19 ratings generated profit

Average Return

+2.54%

Copying Robbie Marcus's trades and holding each position for 3 Months would result in 73.68% of your transactions generating a profit, with an average return of +2.54% per trade.

1 Year

Larry BiegelsenWells Fargo

Success Rate

19/27 ratings generated profit

Average Return

+8.20%

Copying Larry Biegelsen's trades and holding each position for 1 Year would result in 70.37% of your transactions generating a profit, with an average return of +8.20% per trade.

2 Years

Jeff JohnsonRobert W. Baird

Success Rate

24/30 ratings generated profit

Average Return

+16.84%

Copying Jeff Johnson's trades and holding each position for 2 Years would result in 80.00% of your transactions generating a profit, with an average return of +16.84% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SYK Analyst Recommendation Trends

Rating

May 26

Jun 26

Jul 26

Aug 26

Sep 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, SYK has received 34 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. SYK average Analyst price target in the past 3 months is 324.51.

Each month's total comprises the sum of three months' worth of ratings.

SYK Financial Forecast

SYK Earnings Forecast

Next quarter’s earnings estimate for SYK is €3.14 with a range of €3.04 to €3.35. The previous quarter’s EPS was €3.26. SYK beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year SYK has Performed in-line its overall industry.

SYK Sales Forecast

Next quarter’s sales forecast for SYK is €5.86B with a range of €5.80B to €5.93B. The previous quarter’s sales results were €5.82B. SYK beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year SYK has Performed in-line its overall industry.

SYK Stock Forecast FAQ

What is DE:SYK’s average 12-month price target, according to analysts?

Based on analyst ratings, Stryker Corporation’s 12-month average price target is 324.51.

What is DE:SYK’s upside potential, based on the analysts’ average price target?

Stryker Corporation has 14.99% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Stryker Corporation a Buy, Sell or Hold?

Stryker Corporation has a consensus rating of Strong Buy, which is based on 18 buy ratings, 2 hold ratings and 0 sell ratings.

What is Stryker Corporation’s share price target?

The average share price target for Stryker Corporation is 324.51. This is based on 20 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €370.52 ,and the lowest forecast is €262.90. The average share price target represents 14.99% Increase from the current price of €282.2.

What do analysts say about Stryker Corporation?

Stryker Corporation’s analyst rating consensus is a Strong Buy. This is based on the ratings of 20 Wall Streets Analysts.

How can I buy shares of Stryker Corporation?

To buy shares of DE:SYK, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Stryker (SYK) Stock Forecast & Price Target

SYK Analyst Ratings

SYK Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Stryker

SYK Analyst Recommendation Trends

SYK Financial Forecast

SYK Earnings Forecast

SYK Sales Forecast

SYK Stock Forecast FAQ

Detailed List of Analyst Forecasts